calendar
8,580 catalysts · 6,271 phase readout · 2,303 8k filing · 390 earnings · 3 pdufa · 2 approval · 1 adcom
8,580 catalysts · 6,271 phase readout · 2,303 8k filing · 390 earnings · 3 pdufa · 2 approval · 1 adcom
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 1.01, 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 8.01, 9.01
Items: 2.02
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 1.01, 3.02, 8.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 5.02, 9.01
Items: 1.01, 2.03, 9.01
Items: 8.01
Items: 1.01, 2.03, 3.02, 9.01
Items: 1.01, 9.01
Items: 1.01, 3.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 8.01, 9.01
Items: 1.01, 9.01
Items: 2.02, 9.01
Items: 5.07
Items: 1.01, 5.08, 9.01
Items: 8.01, 9.01
Items: 5.02
This page contains notices of advisory committee meetings. Refer to the individual meeting link below for more information on the anticipated format of each meeting. For previous years' advisory committee calendars, see the FDA Archive.
Items: 8.01, 9.01
Items: 1.01, 2.03, 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 7.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 5.02, 7.01, 9.01
Items: 2.02, 7.01, 9.01